D. Lublin

发表

Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interaction

B. Nowicki, A. Hart, K. Coyne, 1993, The Journal of experimental medicine.

Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor.

T. Fujita, T. Kinoshita, K. Coyne, 1992, Journal of immunology.

The human cell-surface glycoproteins HuLy-m5, membrane co-factor protein (MCP) of the complement system, and trophoblast leucocyte-common (TLX) antigen, are CD46.

D. Purcell, J. Atkinson, D. Lublin, 1990, Immunology.

Mucosal prostanoid receptors and synthesis in familial adenomatous polyposis

D. Lublin, J. Roche, K. Lynch, 2001, Histochemistry and Cell Biology.

Biosynthesis and glycosylation of the human complement regulatory protein decay-accelerating factor.

M. Pangburn, J. Atkinson, D. Lublin, 1986, Journal of immunology.

Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46).

J. Atkinson, D. Lublin, D. Lublin, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Normal polymorphic variations and transcription of the decay accelerating factor gene in paroxysmal nocturnal hemoglobinuria cells.

J. Atkinson, V. Holers, M. Tykocinski, 1988, Proceedings of the National Academy of Sciences of the United States of America.

B. Nowicki, A. Hart, D. Lublin, 1995, Infection and immunity.

The polymorphism of the C3b/C4b receptor in the normal population and in patients with systemic lupus erythematosus.

J. Atkinson, V. Holers, D. Lublin, 1987, Clinical and experimental immunology.

Mechanisms of the CYNAP phenomenon: evidence in the Bw49/Bw50 model for epitopes with different spatial orientation of antibody.

D. Lublin, F. Grumet, 1982, Human immunology.

The gene encoding decay-accelerating factor (DAF) is located in the complement-regulatory locus on the long arm of chromosome 1

M. L. Le Beau, J. Atkinson, V. Holers, 1987, The Journal of experimental medicine.

Structural gene for human membrane cofactor protein (MCP) of complement maps to within 100 kb of the 3' end of the C3b/C4b receptor gene

R. Hockett, J. Atkinson, V. Holers, 1989, The Journal of experimental medicine.

A polymorphism of the complement regulatory protein MCP (membrane cofactor protein or gp45-70).

J. Atkinson, D. Lublin, J. Teckman, 1987, Journal of immunology.

Role of Decay-Accelerating Factor Domains and Anchorage in Internalization of Dr-Fimbriated Escherichia coli

R. Selvarangan, B. Nowicki, D. Lublin, 2000, Infection and Immunity.

Terminology for blood group antigens and genes—historical origins and guidelines in the new millennium

D. Lublin, W. Dzik, G. Garratty, 2000, Transfusion.

Decay-accelerating factor: biochemistry, molecular biology, and function.

J. Atkinson, D. Lublin, 1989, Annual review of immunology.

Decay-Accelerating Factor: Biochemistry, Molecular Biology, and Function

J. Atkinson, D. Lublin, 1989 .

Control of the complement system.

J. Atkinson, D. Lublin, D. Lublin, 1996, Advances in immunology.

Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP). Evidence for inclusion in the multigene family of complement-regulatory proteins

M. L. Le Beau, J. Atkinson, D. Lublin, 1988, The Journal of experimental medicine.

Decay-accelerating factor and membrane cofactor protein.

J. Atkinson, D. Lublin, D. Lublin, 1990, Current topics in microbiology and immunology.

Molecular mapping of the Cromer blood group Cra and Tca epitopes of decay accelerating factor: toward the use of recombinant antigens in immunohematology.

D. Lublin, M. Udani, R. Kaufman, 1994, Blood.

Identification of 5'-flanking regions affecting the expression of the human decay accelerating factor gene and their role in tissue-specific expression.

D. Lublin, D. Thomas, 1993, Journal of immunology.

Review: Cromer and DAF: role in health and disease

D. Lublin, D. Lublin, 2005, Immunohematology.

Molecular basis of Cromer blood group antigens

D. Lublin, M. Reid, S. Kompelli, 2000, Transfusion.

Location of WESb on decay‐accelerating factor

M. Telen, D. Lublin, N. Rao, 1995, Transfusion.

Human C3b- and C4b-regulatory proteins: a new multi-gene family.

J. Atkinson, V. Holers, D. Lublin, 1985, Immunology today.

Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement.

J. Atkinson, J. Leykam, V. Holers, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Characterization of DAF-2, a high molecular weight form of decay-accelerating factor (DAF; CD55), as a covalently cross-linked dimer of DAF-1.

J. Atkinson, D. Lublin, J. Alvarez, 1994, Journal of immunology.

Human genes for three complement components that regulate the activation of C3 are tightly linked

S. Rodríguez de Córdoba, J. Atkinson, D. Lublin, 1985, The Journal of experimental medicine.

Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H.

D. Lublin, D. Lublin, T. Blackmore, 1996, Journal of immunology.

Identification of complement regulatory domains in human factor H.

D. Lublin, D. Lublin, T. Blackmore, 1995, Journal of immunology.

Activation of the gene encoding decay accelerating factor following nerve growth factor treatment of sensory neurons is mediated by promoter sequences within 206 bases of the transcriptional start site

D. Latchman, E. Ensor, D. Lublin, 1996, Journal of neuroscience research.

CD46 (Huly-m5) antigen of humans includes the trophoblast — leukocyte antigen (TLX) and the membrane co-factor protein (MCP) of complement

D. Purcell, J. Atkinson, D. Lublin, 1989 .